Sensitivity and specificity of anti-HBc screening assays - Which assay is best for blood donor screening?

International Journal of Laboratory Hematology

Volumn 31, Issue 6, 2009, Pages 649-656

  Hourfar, M K ^a   Walch, L A ^a   Geusendam, G ^b   Dengler, T ^b   Janetzko, K ^b   Gubbe, K ^b   Frank, K ^b   Karl, A ^b   Lohr M ^c   Sireis, W ^a   Seifried, E ^a   Schmidt, M ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Institute Springe   (Germany)

^c Institute of Transfusion Medicine and Immunohematology   (Germany)

Author keywords

Anti HBc assays; Blood donor screening; ChLIA; EIA; HBV minipool

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B(E) ANTIBODY; VIRUS DNA; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; ASSAY; BLOOD DONOR; CONTROLLED STUDY; DONOR; GEOGRAPHIC DISTRIBUTION; HEPATITIS B VIRUS; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; REPEAT PROCEDURE; SCREENING; SENSITIVITY AND SPECIFICITY; BLOOD; DONOR SELECTION; GERMANY; HEPATITIS B; IMMUNOLOGY; INFECTION CONTROL;

BLOOD DONORS; COMMUNICABLE DISEASE CONTROL; DNA, VIRAL; DONOR SELECTION; GERMANY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 74049143118     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01092.x     Document Type: Article

References (15)

1. Alhababi F., Sallam T.A. & Tong C.Y. (2003) The significance of 'anti-HBc only' in the clinical virology laboratory. Journal of Clinical Virology 27, 162-169.
2. Burger R. &Offergeld R. (2005) Erhöhung der Sicherheit von zellularen Blutkom- ponenten und quarantanegelagertem Frischplasma durch Untersuchung der Blut- und Plasmaspenden auf Antikörper gegen das Hepatitis-B-Core-Antigen. Bundesgesundheitsbl 48, 698-699.
3. Cheng Y., Dubovoy N., Hayes-Rogers M.E., Stewart J. & Shah D. (1999) Detection of IgM to hepatitis B core antigen in a reductant containing, chemiluminescence assay. Journal of Immunological Methods 230, 29-35.
4. Dane D.S., Cameron C.H. & Briggs M. (1970) Virus like particles in serum of patients with Australia antigen associated hepatitis. Lancet 1, 695-698.
5. Drosten C., Weber M., Seifried E. & Roth W.K. (2000) Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening. Transfusion 40, 718-724.
6. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E. & Margolis H.S. (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. International Journal of Epidemiology 34, 1329-1339.
7. Grob P., Jilg W., Bornhak H., Gerken G., Gerlich W., Gunther S., Hess G., Hudig H., Kitchen A., argolis H., Michel G., Trepo C., Will H., Zanetti A. & Mushahwar I. (2000) Serological pattern "anti-HBc alone": report on a workshop. Journal of Medical Virology 62, 450-455.
8. Hochberger S., Althof D., Gallegos de Schrott R., Nachbaur N., Rock H. & Leying H. (2006) Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS Ampli- Prep/COBAS TaqMan system. Journal of Clinical Virology 35, 373-380.
9. Komiya Y., Katayama K., Yugi H., Mizui M., Matsukura H., Tomoguri T., Miyakawa Y., Tabuchi A., Tanaka J. &Yoshizawa H. (2008) Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia betweeen genotype A and genotype C. Transfusion 48, 286-294.
10. McMahon B.J. (2005) Epidemiology and natural history of hepatitis B. Seminars in Liver Disease 25(Suppl. 1), 3-8.
11. Meyer C., Reiter S., Siedler A., Hellen- brand W. &Rasch G. (2002) The importance of vaccination. Bundes- gesundheitsbl 45, 323-331. Mosley J.W., Stevens C.E., Aach R.D., Hollinger F.B., Mimms L.T., Solomon L.R., Barbosa L.H. &Nemo G.J. (1995) Donor screening for antibody to hepati tis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 35, 5-12.
12. Roth W.K., Weber M. &Seifried E. (1999) Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 353, 359-363.
13. Roth W.K., Weber M., Petersen D., Dros- ten C., Buhr S., Sireis W., Weichert W., Hedges D. &Seifried E. (2002) NAT for HBV and anti-HBc testing increase blood safety. Transfusion 42, 869-875.
14. Schmidt M., Nubling C.M., Scheiblauer H., Chudy M., Walch L.A., Seifried E., Roth W.K. &Hourfar M.K. (2006) Anti- HBc screening of blood donors: a comparison of nine anti-HBc tests. Vox Sanguinis 91, 237-243.
15. Zerlauth G. (1999) Assessment of valida tion studies from a fractionator's point of view. Biologicals 27, 295-301.